Verastem, Inc. (VSTM)
Health Care ยท Pharmaceutical Preparations
Verastem, Inc. (VSTM) is listed on Nasdaq, where its shares have traded since January 27, 2012. SentiSense covers Verastem, Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations. Daniel W. Paterson is its chief executive officer. The company reports 102 employees, and its corporate website is www.verastem.com.
About Verastem, Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Latest reported results
Verastem, Inc. reported revenue of $24.0 million for Q3 FY2026, up 113.6% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 151 institutions reported holding VSTM, with 94.5 million shares worth $361.3 million in aggregate. The largest reported holders were BlackRock, Vanguard and Armistice Capital. Of the 5 largest reported holders, 4 added shares and 1 held its position unchanged during the quarter.
More on VSTM
- VSTM sentiment: whether news and social coverage of Verastem, Inc. leans bullish or bearish, and the stories driving it.
- VSTM ownership: all 151 reporting institutions, plus insider and congressional trades.
- VSTM financials: revenue, net income, operating margin and free cash flow through Q3 FY2026.
SentiSense also tracks daily options readings for Verastem, Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Verastem, Inc. do?
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer.
What sector is VSTM in?
SentiSense classifies Verastem, Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations.
Where does VSTM stock trade?
Verastem, Inc. (VSTM) is listed on Nasdaq, where its shares have traded since January 27, 2012.
Who is the CEO of Verastem, Inc.?
Daniel W. Paterson is the chief executive officer of Verastem, Inc..